annual cash & cash equivalents:
$107.62M+$24.65M(+29.71%)Summary
- As of today (September 16, 2025), TRVI annual cash & cash equivalents is $107.62 million, with the most recent change of +$24.65 million (+29.71%) on December 31, 2024.
- During the last 3 years, TRVI annual cash & cash equivalents has risen by +$70.79 million (+192.21%).
- TRVI annual cash & cash equivalents is now -10.69% below its all-time high of $120.51 million, reached on December 31, 2022.
Performance
TRVI Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$203.88M+$100.63M(+97.45%)Summary
- As of today (September 16, 2025), TRVI quarterly cash & cash equivalents is $203.88 million, with the most recent change of +$100.63 million (+97.45%) on June 30, 2025.
- Over the past year, TRVI quarterly cash & cash equivalents has increased by +$134.39 million (+193.38%).
- TRVI quarterly cash & cash equivalents is now at all-time high.
Performance
TRVI quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TRVI Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.7% | +193.4% |
| 3 y3 years | +192.2% | +161.9% |
| 5 y5 years | +87.8% | +361.5% |
TRVI Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.7% | +192.2% | at high | +211.3% |
| 5 y | 5-year | -10.7% | +192.2% | at high | +600.3% |
| alltime | all time | -10.7% | +1394.3% | at high | +825.9% |
TRVI Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $203.88M(+97.5%) |
| Mar 2025 | - | $103.26M(-4.1%) |
| Dec 2024 | $107.62M(+29.7%) | $107.62M(+64.3%) |
| Sep 2024 | - | $65.49M(-5.8%) |
| Jun 2024 | - | $69.50M(-4.6%) |
| Mar 2024 | - | $72.82M(-12.2%) |
| Dec 2023 | $82.97M(-31.2%) | $82.97M(-6.6%) |
| Sep 2023 | - | $88.87M(-5.6%) |
| Jun 2023 | - | $94.15M(-15.4%) |
| Mar 2023 | - | $111.26M(-7.7%) |
| Dec 2022 | $120.51M | $120.51M(-4.1%) |
| Sep 2022 | - | $125.60M(+61.3%) |
| Jun 2022 | - | $77.86M(+167.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $29.11M(-21.0%) |
| Dec 2021 | $36.83M(-18.2%) | $36.83M(+25.6%) |
| Sep 2021 | - | $29.32M(-19.5%) |
| Jun 2021 | - | $36.42M(-12.4%) |
| Mar 2021 | - | $41.57M(-7.6%) |
| Dec 2020 | $45.00M(-21.5%) | $45.00M(-15.6%) |
| Sep 2020 | - | $53.29M(+20.6%) |
| Jun 2020 | - | $44.18M(-16.1%) |
| Mar 2020 | - | $52.64M(+139.1%) |
| Dec 2019 | $57.31M(+695.8%) | - |
| Dec 2018 | $7.20M(-67.3%) | - |
| Dec 2017 | $22.02M(+165.7%) | - |
| Dec 2017 | - | $22.02M |
| Dec 2016 | $8.29M | - |
FAQ
- What is Trevi Therapeutics, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
- What is Trevi Therapeutics, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Trevi Therapeutics, Inc.?
- What is Trevi Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
What is Trevi Therapeutics, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of TRVI is $107.62M
What is the all time high annual cash & cash equivalents for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high annual cash & cash equivalents is $120.51M
What is Trevi Therapeutics, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, TRVI annual cash & cash equivalents has changed by +$24.65M (+29.71%)
What is Trevi Therapeutics, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TRVI is $203.88M
What is the all time high quarterly cash & cash equivalents for Trevi Therapeutics, Inc.?
Trevi Therapeutics, Inc. all-time high quarterly cash & cash equivalents is $203.88M
What is Trevi Therapeutics, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, TRVI quarterly cash & cash equivalents has changed by +$134.39M (+193.38%)